Biochemist Svetlana Mojsov, honored for GLP-1 research that has transformed metabolic disease care, says she’s grateful to ...

Discover why Takeda Pharmaceutical Company Limited remains a solid Buy. Click to explore TAK and its drug pipeline, growth ...

It’s increasingly clear that “payment conservativism” — avoiding paying too much to medical research participants — is the ...

Trump floated proposed tariffs potentially as high as 200 per cent. But he also said these would not be imposed for “ about a ...

Analysts are calling for 25% top-line growth from Intuitive Surgical this year, to be followed by 15% and 17% revenue growth ...

The news comes as the administration is pushing for pharmaceutical manufacturers reshore drug production in the United States.

Would you get a one-time genetic modification such that you'd never have to take a GLP-1 drug for weight loss ever again?

Each year, approximately 20 million people are diagnosed with cancer, and nearly 10 million lives are lost to the disease ...

83% of pharmaceutical companies—including many contract development and manufacturing organizations (CDMOs)—operate without basic technical safeguards.